Management of Chronic Hepatitis C at a Primary Health Clinic in the High-Burden Context of Karachi, Pakistan
Van den Bergh, R
Van Overloop, C
MetadataShow full item record
AbstractThe burden of hepatitis C (HCV) infection in Pakistan is among the highest in the world, with a reported national HCV prevalence of 6.7% in 2014. In specific populations, such as in urban communities in Karachi, the prevalence is suspected to be higher. Interferon-free treatment for chronic HCV infection (CHC) could allow scale up, simplification and decentralization of treatment to such communities. We present an interim analysis over the course of February-December 2015 of an interferon-free, decentralised CHC programme in the community clinic in Machar Colony, Karachi, Pakistan.
PublisherPublic Library of Science
- Sofosbuvir-Containing Regimens for Chronic Hepatitis C Are Successful in the Safety-Net Population: A Real-World Experience.
- Authors: Beck KR, Kim N, Khalili M
- Issue date: 2016 Dec
- Dramatic response of hepatitis C patients chronically infected with hepatitis C virus genotype 3 to sofosbuvir-based therapies in Punjab, Pakistan: A prospective study.
- Authors: Iqbal S, Yousuf MH, Yousaf MI
- Issue date: 2017 Nov 28
- Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation.
- Authors: Hartwell D, Jones J, Baxter L, Shepherd J
- Issue date: 2011 Apr
- Cost-effectiveness of sofosbuvir plus ribavirin with or without pegylated interferon for the treatment of chronic hepatitis C in Italy.
- Authors: Cure S, Guerra I, Cammà C, Craxì A, Carosi G
- Issue date: 2015
- Antiviral regimen complexity index as an independent predictor of sustained virologic response in patients with chronic hepatitis C.
- Authors: Galán RJ, Cidoncha EC, Martin MF, Rodriguez CC, Almeida CV, Verdugo RM
- Issue date: 2013 Jul-Aug